Cargando…
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
SIMPLE SUMMARY: The breakthrough of immunotherapy in melanoma has generated a glimmer of hope for lethal triple negative breast cancer (TNBC). This review summarizes the recent advances, challenges and potential new approaches of immunotherapy in TNBC. ABSTRACT: With improved understanding of the im...
Autores principales: | Mediratta, Karan, El-Sahli, Sara, D’Costa, Vanessa, Wang, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761500/ https://www.ncbi.nlm.nih.gov/pubmed/33256070 http://dx.doi.org/10.3390/cancers12123529 |
Ejemplares similares
-
Applications of Extracellular Vesicles in Triple-Negative Breast Cancer
por: St-Denis-Bissonnette, Frederic, et al.
Publicado: (2022) -
Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
por: Yang, Ruoning, et al.
Publicado: (2022) -
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022) -
Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022) -
Research progress on immunotherapy in triple-negative breast cancer (Review)
por: Zhang, Xiaoxiao, et al.
Publicado: (2022)